IGHE and asthma: The type 2 inflammatory asthma phenotype, which is estimated to affect at least 50% of all asthma patients [4], is characterized by elevated type 2 biomarkers, including blood and sputum eosinophils, immunoglobulin E (IgE), and fractional concentration of exhaled nitric oxide (FeNO) [5–7].